Valemetostat Tosylate clinical trials

Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01)

This study looks at a new medicine called Valemetostat Tosylate for people with certain types of T-cell lymphoma that has come back or not responded to previous treatments. It aims to see how safe and effective the medicine is.